NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/04/2024
Back to search
Official data from USPTO
EMPIRE DISCOVERY INSTITUTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
06/04/2024
Trademark type
Combined
Nice classes
35, 36
Filing date
05/12/2023
Registration date
06/04/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
06/04/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2019-12-00
First use in commerce
2019-12-00
Drawing code
3
Owner type
99
Owner location
Rochester, NY, US
Examiner
BARANDAO, CHERISE DESIRIMA
Law office
N90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "Empire" above "Discovery" above "Institute", all appearing to the right of a stylized double helix design.
Holders and representatives
Holders
Empire Discovery Institute, Inc.
Representatives
Anne F. Downey HARTER SECREST & EMERY LLP
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
providing business consulting services for life science incubator and accelerator servicesproviding assistance in the commercialization of products and services in the field of pharmaceuticals; providing business consulting services in the area of sourcing investments and partners for advancing medical research projects; promoting collaboration within the scientificresearchpharmaceuticalmedical communities to achieve advances in healthcareincluding to accelerate the development and use of drugs for the treatment of disease
Class 36
providing financing to entrepreneursearly-stageemerging and start-up companies and founders in the fields of drug discovery and development; providing project grants for research and development in the pharmaceuticalbiotechnology and medical fields
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/19/2024
PUBO
PUBLISHED FOR OPPOSITION
03/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2024
GNRT
NON-FINAL ACTION E-MAILED
02/07/2024
CNRT
NON-FINAL ACTION WRITTEN
02/07/2024
DOCK
ASSIGNED TO EXAMINER
02/06/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/13/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2023
NWAP
NEW APPLICATION ENTERED
05/16/2023
Continuous trademark protection
Get notified about every new filing that threatens EMPIRE DISCOVERY INSTITUTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.